Reply to “A better interpretation of data regarding the opioid switching to methadone”

Abstract

Abstract In our article ?Methadone switching for refractory cancer pain’ (BMC palliative care, 2022) we explore the efficacy, safety and economics of methadone in treatment of patients with refractory cancer pain in China. Professor Mercadante provided a better interpretation of data regarding the opioid switching to methadone in the Matters Arising. In this article, we answered the questions in Mercadante et al.’s comments one by one.

Keywords

• Cancer pain
• Opioid switching or rotation
• Methadone
• Palliative care